Literature DB >> 15471661

CT screening for lung cancer Assessing a regimen's diagnostic performance.

Claudia I Henschke1, David F Yankelevitz, James P Smith, Daniel Libby, Mark Pasmantier, Dorothy McCauley, Georgeann McGuinness, David P Naidich, Ali Farooqi, Madeline Vasquez, Olli S Miettinen.   

Abstract

PURPOSE: The purpose of this study was to characterize the diagnostic performance of a regimen of CT screening for lung cancer.
METHODS: Using a common protocol/regimen of screening, 2968 asymptomatic persons at high risk for lung cancer were enrolled in two studies [Early Lung Cancer Action Projects (ELCAP) I and II] for baseline and annual repeat screening. A total of 4538 annual repeat screenings were performed. The regimen's diagnostic performance was characterized in terms of frequency of positive result of the initial CT as well as of screen-diagnosis and Stage I screen-diagnosis among all diagnoses (interim-diagnoses included), all separately for baseline and annual repeat screenings.
RESULTS: The proportions with positive result of the initial CT were 12% and 6% in the baseline and repeat screenings, respectively. The proportions of screen-diagnoses among all diagnoses (interim-diagnoses included) were 97% and 99% in the baseline and repeat cycles, respectively. The corresponding proportions of pre-surgical Stage I screen-diagnoses were 95% and 93%.
CONCLUSION: The performance of the ELCAP regimen is quite satisfactory in avoiding over many positive results of the initial CT, and it produces highly promising diagnostic results as for the attainment of cure by early intervention.

Entities:  

Mesh:

Year:  2004        PMID: 15471661     DOI: 10.1016/j.clinimag.2004.05.001

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  4 in total

1.  [Primary lung cancer in Chinese renal transplant recipients: a single-center analysis].

Authors:  Shu-Xin Zhang; Yang Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-06-20

2.  Type and case volume of health care facility influences survival and surgery selection in cases with early-stage non-small cell lung cancer.

Authors:  Shidan Wang; Sunny Lai; Mitchell S von Itzstein; Lin Yang; Donghan M Yang; Xiaowei Zhan; Guanghua Xiao; Ethan A Halm; David E Gerber; Yang Xie
Journal:  Cancer       Date:  2019-09-10       Impact factor: 6.860

3.  Management of SPN in France. Pathways for definitive diagnosis of solitary pulmonary nodule: a multicentre study in 18 French districts.

Authors:  Kazem Alzahouri; Michel Velten; Patrick Arveux; Marie-Christine Woronoff-Lemsi; Damien Jolly; Francis Guillemin
Journal:  BMC Cancer       Date:  2008-04-10       Impact factor: 4.430

4.  Diagnosis of Lung Cancer by Fractal Analysis of Damaged DNA.

Authors:  Hamidreza Namazi; Mona Kiminezhadmalaie
Journal:  Comput Math Methods Med       Date:  2015-10-11       Impact factor: 2.238

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.